Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients

Lea S Eiland1, Thomas M English, Edward H Eiland

  • 1Auburn University Harrison School of Pharmacy, Huntsville, AL, USA. eilanls@auburn.edu

Insights

Pediatric vancomycin dosing often leads to subtherapeutic levels. Increased dosages are necessary to achieve target vancomycin trough concentrations (10-20 mg/L) in children, addressing microbial resistance concerns.

Area of Science:

  • Pediatric pharmacology
  • Infectious disease management

Background:

  • Rising microbial resistance to vancomycin necessitates higher therapeutic drug concentrations.
  • Adult guidelines suggest increased vancomycin trough concentrations, principles applicable to pediatric care.
  • Higher target serum concentrations require escalated vancomycin dosages in children.

Purpose of the Study:

  • Evaluate current vancomycin dosing and resulting serum concentrations in pediatric patients.
  • Compare pediatric vancomycin regimens against established guidelines.
  • Develop a predictive equation for optimal vancomycin dosing in children.

Main Methods:

  • Retrospective chart review of pediatric patients receiving vancomycin (2005-2010).
  • Analysis of pharmacokinetic parameters, vancomycin dosages, and serum concentrations.
  • Comparison of therapeutic serum concentrations with prescribing guidelines.

Main Results:

  • Analysis of 435 trough concentrations from 295 pediatric patients.
  • Vancomycin dosages averaged 48 mg/kg/day (2005-2008) and 59 mg/kg/day (2009-2010).
  • Therapeutic vancomycin levels (5-15 mg/L) achieved in 78% (2005-2008) but only 49% (2009-2010) with 10-20 mg/L targets.
  • A predictive equation suggests 70-85 mg/kg/day is needed for 10-15 mg/L trough concentrations.

Conclusions:

  • Pediatric vancomycin dosing (40-60 mg/kg/day) often yields subtherapeutic levels based on current recommendations.
  • Increased total daily vancomycin dosage is required to achieve target trough concentrations (10-20 mg/L).
  • Optimized dosing is crucial for effective treatment and combating antimicrobial resistance in children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...